High materiality7/10
Guardant Health price target raised to $220 from $200 at Barclays
Why it may matterVerify against the original reporting
buy
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Barclays raises Guardant Health target to 220; current price 170.69.
- Barclays target up to 220; price 170.69.
Key facts
- 01
Target: $220
- 02
Posted price: $170.69
- 03
Analyst firm: Barclays
- 04
Analyst: Luke Sergott
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.